{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:13:51Z","timestamp":1794370431710,"version":"4.9.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370998"],"award-info":[{"award-number":["32370998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82061138006"],"award-info":[{"award-number":["82061138006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011468"],"award-info":[{"award-number":["2023A1515011468"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53242-0","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T19:01:55Z","timestamp":1729105315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Xinglong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmiao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-3101","authenticated-orcid":false,"given":"Yiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3964-1740","authenticated-orcid":false,"given":"Linbing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-6349","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-1626","authenticated-orcid":false,"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-2987","authenticated-orcid":false,"given":"Linping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-2074","authenticated-orcid":false,"given":"Liqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"53242_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","volume":"560","author":"TC Pierson","year":"2018","unstructured":"Pierson, T. C. & Diamond, M. S. The emergence of Zika virus and its new clinical syndromes. Nature 560, 573\u2013581 (2018).","journal-title":"Nature"},{"key":"53242_CR2","unstructured":"https:\/\/www.who.int\/publications\/m\/item\/zika-epidemiology-update-may-2024."},{"key":"53242_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMra1808246","volume":"381","author":"D Musso","year":"2019","unstructured":"Musso, D., Ko, A. I. & Baud, D. Zika Virus Infection - After the Pandemic. N. Engl. J. Med. 381, 1444\u20131457 (2019).","journal-title":"N. Engl. J. Med."},{"key":"53242_CR4","doi-asserted-by":"publisher","unstructured":"Silva, N. M., Santos, N. C. & Martins, I. C. Dengue and Zika Viruses: Epidemiological History, Potential Therapies, and Promising Vaccines. Tropic.medicine and infectious disease 5, https:\/\/doi.org\/10.3390\/tropicalmed5040150 (2020).","DOI":"10.3390\/tropicalmed5040150"},{"key":"53242_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","volume":"24","author":"AM Fowler","year":"2018","unstructured":"Fowler, A. M. et al. Maternally acquired zika antibodies enhance dengue disease severity in mice. Cell Host Microbe 24, 743\u2013750.e745 (2018).","journal-title":"Cell Host Microbe"},{"key":"53242_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick, L. C. et al. Zika virus infection enhances future risk of severe dengue disease. Science 369, 1123\u20131128 (2020).","journal-title":"Science"},{"key":"53242_CR7","doi-asserted-by":"publisher","first-page":"572681","DOI":"10.3389\/fcimb.2020.572681","volume":"10","author":"R Shukla","year":"2020","unstructured":"Shukla, R., Ramasamy, V., Shanmugam, R. K., Ahuja, R. & Khanna, N. Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect. Microbiol 10, 572681 (2020).","journal-title":"Front Cell Infect. Microbiol"},{"key":"53242_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","volume":"169","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against zika virus infection. Cell 169, 176 (2017).","journal-title":"Cell"},{"key":"53242_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41590-021-00966-6","volume":"22","author":"L Dai","year":"2021","unstructured":"Dai, L. et al. Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. Nat. Immunol. 22, 958\u2013968 (2021).","journal-title":"Nat. Immunol."},{"key":"53242_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12677-6","volume":"10","author":"SW Metz","year":"2019","unstructured":"Metz, S. W. et al. Oligomeric state of the ZIKV E protein defines protective immune responses. Nat. Commun. 10, 4606 (2019).","journal-title":"Nat. Commun."},{"key":"53242_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","volume":"20","author":"JL Slon-Campos","year":"2019","unstructured":"Slon-Campos, J. L. et al. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection. Nat. Immunol. 20, 1291\u20131298 (2019).","journal-title":"Nat. Immunol."},{"key":"53242_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"53242_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443\u2013447 (2016).","journal-title":"Nature"},{"key":"53242_CR14","doi-asserted-by":"publisher","unstructured":"Lopez-Camacho, C. et al. Immunogenicity and efficacy of zika virus envelope domain iii in dna, protein, and chadox1 adenoviral-vectored vaccines. Vaccines (Basel) 8, https:\/\/doi.org\/10.3390\/vaccines8020307 (2020).","DOI":"10.3390\/vaccines8020307"},{"key":"53242_CR15","doi-asserted-by":"publisher","first-page":"905431","DOI":"10.3389\/fimmu.2022.905431","volume":"13","author":"H Rong","year":"2022","unstructured":"Rong, H. et al. Self-assembling nanovaccine confers complete protection against zika virus without causing antibody-dependent enhancement. Front. Immunol. 13, 905431 (2022).","journal-title":"Front. Immunol."},{"key":"53242_CR16","doi-asserted-by":"publisher","unstructured":"Carpio, K. L. & Barrett, A. D. T. Flavivirus NS1 and Its Potential in Vaccine Development. Vaccines 9, https:\/\/doi.org\/10.3390\/vaccines9060622 (2021).","DOI":"10.3390\/vaccines9060622"},{"key":"53242_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fmicb.2020.00362","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun, J., Du, S., Zheng, Z., Cheng, G. & Jin, X. Defeat dengue and zika viruses with a one-two punch of vaccine and vector blockade. Front. Microbiol. 11, 362 (2020).","journal-title":"Front. Microbiol."},{"key":"53242_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","volume":"26","author":"H Puerta-Guardo","year":"2019","unstructured":"Puerta-Guardo, H. et al. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 26, 1598\u20131613 e1598 (2019).","journal-title":"Cell Rep."},{"key":"53242_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.abc0476","volume":"371","author":"SB Biering","year":"2021","unstructured":"Biering, S. B. et al. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. Science 371, 194\u2013200 (2021).","journal-title":"Science"},{"key":"53242_CR20","doi-asserted-by":"publisher","unstructured":"Yu, L. et al. Monoclonal antibodies against zika virus ns1 protein confer protection via fcgamma receptor-dependent and -independent pathways. Mbio 12, https:\/\/doi.org\/10.1128\/mBio.03179-20 (2021).","DOI":"10.1128\/mBio.03179-20"},{"key":"53242_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1126\/science.abb9425","volume":"371","author":"N Modhiran","year":"2021","unstructured":"Modhiran, N. et al. A broadly protective antibody that targets the flavivirus NS1 protein. Science 371, 190\u2013194 (2021).","journal-title":"Science"},{"key":"53242_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19096-y","volume":"11","author":"AW Wessel","year":"2020","unstructured":"Wessel, A. W. et al. Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy. Nat. Commun. 11, 5278 (2020).","journal-title":"Nat. Commun."},{"key":"53242_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07008-0","volume":"9","author":"MJ Bailey","year":"2018","unstructured":"Bailey, M. J. et al. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nat. Commun. 9, 4560 (2018).","journal-title":"Nat. Commun."},{"key":"53242_CR24","doi-asserted-by":"publisher","unstructured":"Bailey, M. J. et al. Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus. Mbio 10, https:\/\/doi.org\/10.1128\/mBio.02861-18 (2019).","DOI":"10.1128\/mBio.02861-18"},{"key":"53242_CR25","doi-asserted-by":"publisher","first-page":"eaax2388","DOI":"10.1126\/sciadv.aax2388","volume":"5","author":"B Grubor-Bauk","year":"2019","unstructured":"Grubor-Bauk, B. et al. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice. Sci. Adv. 5, eaax2388 (2019).","journal-title":"Sci. Adv."},{"key":"53242_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15039-8","volume":"7","author":"AC Brault","year":"2017","unstructured":"Brault, A. C. et al. A zika vaccine targeting ns1 protein protects immunocompetent adult mice in a lethal challenge model. Sci. Rep. 7, 14769 (2017).","journal-title":"Sci. Rep."},{"key":"53242_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00464-2","volume":"7","author":"D Kurup","year":"2022","unstructured":"Kurup, D. et al. Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. NPJ Vaccines 7, 43 (2022).","journal-title":"NPJ Vaccines"},{"key":"53242_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/d41586-023-03058-7","volume":"622","author":"E Dolgin","year":"2023","unstructured":"Dolgin, E. Why rings of RNA could be the next blockbuster drug. Nature 622, 22\u201324 (2023).","journal-title":"Nature"},{"key":"53242_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","volume":"8","author":"D Niu","year":"2023","unstructured":"Niu, D., Wu, Y. & Lian, J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct. Target Ther. 8, 341 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"53242_CR30","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728\u20131744 e1716 (2022).","journal-title":"Cell"},{"key":"53242_CR31","doi-asserted-by":"publisher","first-page":"110901","DOI":"10.1016\/j.celrep.2022.110901","volume":"39","author":"DM Hinke","year":"2022","unstructured":"Hinke, D. M. et al. Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses. Cell Rep. 39, 110901 (2022).","journal-title":"Cell Rep."},{"key":"53242_CR32","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.4049\/jimmunol.0903296","volume":"184","author":"T Suzuki","year":"2010","unstructured":"Suzuki, T. et al. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J. Immunol. 184, 1968\u20131976 (2010).","journal-title":"J. Immunol."},{"key":"53242_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fimmu.2020.01393","volume":"11","author":"F Junker","year":"2020","unstructured":"Junker, F., Gordon, J. & Qureshi, O. Fc gamma receptors and their role in antigen uptake, presentation, and t cell activation. Front Immunol. 11, 1393 (2020).","journal-title":"Front Immunol."},{"key":"53242_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2024.05.004","author":"MY Kim","year":"2024","unstructured":"Kim, M. Y., Mason, H. S., Ma, J. K. C. & Reljic, R. Recombinant immune complexes as vaccines against infectious diseases. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2024.05.004 (2024).","journal-title":"Trends Biotechnol."},{"key":"53242_CR35","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1128\/JVI.76.9.4634-4642.2002","volume":"76","author":"X Yang","year":"2002","unstructured":"Yang, X. et al. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin. J. Virol. 76, 4634\u20134642 (2002).","journal-title":"J. Virol."},{"key":"53242_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).","journal-title":"Nat. Commun."},{"key":"53242_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva, N. S. & Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15, 137\u2013148 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"53242_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw, B. J., Craft, J. E. & Kaech, S. M. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat. Rev. Immunol. 16, 102\u2013111 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"53242_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0072-6","volume":"3","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Incorporation of NS1 and prM\/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein. NPJ Vaccines 3, 29 (2018).","journal-title":"NPJ Vaccines"},{"key":"53242_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262\u2013272 (2023).","journal-title":"Nat. Biotechnol."},{"key":"53242_CR41","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.ebiom.2020.102991","volume":"60","author":"R Shukla","year":"2020","unstructured":"Shukla, R. et al. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models. EBioMedicine 60, 102991 (2020).","journal-title":"EBioMedicine"},{"key":"53242_CR42","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med 373, 1195\u20131206 (2015).","journal-title":"N. Engl. J. Med"},{"key":"53242_CR43","first-page":"351","volume":"215","author":"S Henein","year":"2017","unstructured":"Henein, S. et al. Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (cyd-tdv) in naive and dengue-exposed individuals. J. Infect. Dis. 215, 351\u2013358 (2017).","journal-title":"J. Infect. Dis."},{"key":"53242_CR44","doi-asserted-by":"publisher","first-page":"e0009258","DOI":"10.1371\/journal.pntd.0009258","volume":"15","author":"LJ White","year":"2021","unstructured":"White, L. J. et al. Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003). PLoS neglected tropical Dis. 15, e0009258 (2021).","journal-title":"PLoS neglected tropical Dis."},{"key":"53242_CR45","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","volume":"32","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Mol. Ther. 32, 1779\u20131789 (2024).","journal-title":"Mol. Ther."},{"key":"53242_CR46","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li, H. et al. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics 12, 6422\u20136436 (2022).","journal-title":"Theranostics"},{"key":"53242_CR47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.it.2017.05.004","volume":"38","author":"NS Lima","year":"2017","unstructured":"Lima, N. S., Rolland, M., Modjarrad, K. & Trautmann, L. T cell immunity and zika virus vaccine development. Trends Immunol. 38, 594\u2013605 (2017).","journal-title":"Trends Immunol."},{"key":"53242_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","volume":"18","author":"SC Kim","year":"2022","unstructured":"Kim, S. C. et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol. Cell Toxicol. 18, 1\u20138 (2022).","journal-title":"Mol. Cell Toxicol."},{"key":"53242_CR49","doi-asserted-by":"publisher","unstructured":"Xia, X. Detailed Dissection and Critical Evaluation of the Pfizer\/BioNTech and Moderna mRNA Vaccines. Vaccines (Basel) 9, https:\/\/doi.org\/10.3390\/vaccines9070734 (2021).","DOI":"10.3390\/vaccines9070734"},{"key":"53242_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.gene.2019.05.008","volume":"707","author":"F Zarghampoor","year":"2019","unstructured":"Zarghampoor, F., Azarpira, N., Khatami, S. R., Behzad-Behbahani, A. & Foroughmand, A. M. Improved translation efficiency of therapeutic mRNA. Gene 707, 231\u2013238 (2019).","journal-title":"Gene"},{"key":"53242_CR51","doi-asserted-by":"publisher","unstructured":"Deviatkin, A. A. et al. Cap-independent circular mrna translation efficiency. Vaccines (Basel) 11, https:\/\/doi.org\/10.3390\/vaccines11020238 (2023).","DOI":"10.3390\/vaccines11020238"},{"key":"53242_CR52","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.aaz9447","volume":"368","author":"TR Kollmann","year":"2020","unstructured":"Kollmann, T. R., Marchant, A. & Way, S. S. Vaccination strategies to enhance immunity in neonates. Science 368, 612\u2013615 (2020).","journal-title":"Science"},{"key":"53242_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00658-2","volume":"8","author":"SJ Thomas","year":"2023","unstructured":"Thomas, S. J. Is new dengue vaccine efficacy data a relief or cause for concern? NPJ vaccines 8, 55 (2023).","journal-title":"NPJ vaccines"},{"key":"53242_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","volume":"29","author":"GI Georgiev","year":"2022","unstructured":"Georgiev, G. I. et al. Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo. Cell Chem. Biol. 29, 811\u2013823 e817 (2022).","journal-title":"Cell Chem. Biol."},{"key":"53242_CR55","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1099\/vir.0.055178-0","volume":"94","author":"XQ Li","year":"2013","unstructured":"Li, X. Q. et al. Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design. J. Gen. Virol. 94, 2191\u20132201 (2013).","journal-title":"J. Gen. Virol."},{"key":"53242_CR56","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102\u20131105 (2021).","journal-title":"Science"},{"key":"53242_CR57","doi-asserted-by":"publisher","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, https:\/\/doi.org\/10.1126\/science.abc8378 (2021).","DOI":"10.1126\/science.abc8378"},{"key":"53242_CR58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 20, 633\u2013643 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"53242_CR59","doi-asserted-by":"publisher","first-page":"580096","DOI":"10.3389\/fcimb.2020.580096","volume":"10","author":"R Narayan","year":"2020","unstructured":"Narayan, R. & Tripathi, S. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection. Front Cell Infect. Microbiol 10, 580096 (2020).","journal-title":"Front Cell Infect. Microbiol"},{"key":"53242_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00426-0","volume":"7","author":"IJ Kim","year":"2022","unstructured":"Kim, I. J. et al. Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets. NPJ Vaccines 7, 9 (2022).","journal-title":"NPJ Vaccines"},{"key":"53242_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00824-0","volume":"9","author":"IJ Kim","year":"2024","unstructured":"Kim, I. J. et al. Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets. NPJ Vaccines 9, 35 (2024).","journal-title":"NPJ Vaccines"},{"key":"53242_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00823-1","volume":"9","author":"IJ Kim","year":"2024","unstructured":"Kim, I. J. et al. Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice. NPJ Vaccines 9, 32 (2024).","journal-title":"NPJ Vaccines"},{"key":"53242_CR63","doi-asserted-by":"publisher","unstructured":"Elong Ngono, A. et al. CD8(+) T cells mediate protection against Zika virus induced by an NS3-based vaccine. Sci. Adv. 6, https:\/\/doi.org\/10.1126\/sciadv.abb2154 (2020).","DOI":"10.1126\/sciadv.abb2154"},{"key":"53242_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4049\/jimmunol.1901289","volume":"205","author":"CW Winkler","year":"2020","unstructured":"Winkler, C. W., Evans, A. B., Carmody, A. B. & Peterson, K. E. Placental Myeloid Cells Protect against Zika Virus Vertical Transmission in a Rag1-Deficient Mouse Model. J. Immunol. 205, 143\u2013152 (2020).","journal-title":"J. Immunol."},{"key":"53242_CR65","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/JVI.02675-12","volume":"87","author":"L Rivino","year":"2013","unstructured":"Rivino, L. et al. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J. Virol. 87, 2693\u20132706 (2013).","journal-title":"J. Virol."},{"key":"53242_CR66","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","volume":"2","author":"J Wen","year":"2017","unstructured":"Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells. Nat. Microbiol 2, 17036 (2017).","journal-title":"Nat. Microbiol"},{"key":"53242_CR67","doi-asserted-by":"publisher","first-page":"104547","DOI":"10.1016\/j.antiviral.2019.104547","volume":"169","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus. Antivir. Res. 169, 104547 (2019).","journal-title":"Antivir. Res."},{"key":"53242_CR68","doi-asserted-by":"publisher","first-page":"e0042323","DOI":"10.1128\/spectrum.00423-23","volume":"11","author":"M Hu","year":"2023","unstructured":"Hu, M. et al. Identification of an arylnaphthalene lignan derivative as an inhibitor against dengue virus serotypes 1 to 4 (denv-1 to -4) using a newly developed denv-3 infectious clone and replicon. Microbiol Spectr. 11, e0042323 (2023).","journal-title":"Microbiol Spectr."},{"key":"53242_CR69","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1080\/15548627.2022.2126614","volume":"19","author":"J Hao","year":"2023","unstructured":"Hao, J. et al. NLRC5 restricts dengue virus infection by promoting the autophagic degradation of viral NS3 through E3 ligase CUL2 (cullin 2). Autophagy 19, 1332\u20131347 (2023).","journal-title":"Autophagy"},{"key":"53242_CR70","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","volume":"93","author":"S Orozco","year":"2012","unstructured":"Orozco, S. et al. Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor. J. Gen. Virol. 93, 2152\u20132157 (2012).","journal-title":"J. Gen. Virol."},{"key":"53242_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41426-017-0007-8","volume":"7","author":"W Tai","year":"2018","unstructured":"Tai, W. et al. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses. Emerg. microbes Infect. 7, 7 (2018).","journal-title":"Emerg. microbes Infect."},{"key":"53242_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biochi.2017.09.011","volume":"142","author":"W Viranaicken","year":"2017","unstructured":"Viranaicken, W. et al. ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates a rapid method of antibody production against emerging pathogens. Biochimie 142, 179\u2013182 (2017).","journal-title":"Biochimie"},{"key":"53242_CR73","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/22221751.2019.1614885","volume":"8","author":"X Niu","year":"2019","unstructured":"Niu, X. et al. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model. Emerg. Microbes Infect. 8, 749\u2013759 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"53242_CR74","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.antiviral.2023.105618","volume":"215","author":"J Yi","year":"2023","unstructured":"Yi, J. et al. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models. Antivir. Res. 215, 105618 (2023).","journal-title":"Antivir. Res"},{"key":"53242_CR75","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1128\/JCM.43.10.4977-4983.2005","volume":"43","author":"BW Johnson","year":"2005","unstructured":"Johnson, B. W., Russell, B. J. & Lanciotti, R. S. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 43, 4977\u20134983 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"53242_CR76","doi-asserted-by":"publisher","unstructured":"Yu, L. et al. Delineating antibody recognition against Zika virus during natural infection. JCI Insight 2, https:\/\/doi.org\/10.1172\/jci.insight.93042 (2017).","DOI":"10.1172\/jci.insight.93042"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53242-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53242-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53242-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T19:03:12Z","timestamp":1729105392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53242-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53242"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53242-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.C. serves as chief scientific advisor for Guangzhou nBiomed Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8932"}}